A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
dc.contributor.author | Lee, Audrey | |
dc.contributor.author | Scott, Madeleine K.D. | |
dc.contributor.author | Wimmers, Florian | |
dc.contributor.author | Arunachalam, Prabhu S. | |
dc.contributor.author | Luo, Wei | |
dc.contributor.author | Fox, Christopher B. | |
dc.contributor.author | Tomai, Mark | |
dc.contributor.author | Khatri, Purvesh | |
dc.contributor.author | Pulendran, Bali | |
dc.contributor.department | Microbiology and Immunology, School of Medicine | en_US |
dc.date.accessioned | 2023-05-09T19:05:28Z | |
dc.date.available | 2023-05-09T19:05:28Z | |
dc.date.issued | 2022-01-27 | |
dc.description.abstract | Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum/Ovalbumin immunization. We find that 3M-052-Alum/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Lee A, Scott MKD, Wimmers F, et al. A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice. Nat Commun. 2022;13(1):549. Published 2022 Jan 27. doi:10.1038/s41467-022-28197-9 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/32859 | |
dc.language.iso | en_US | en_US |
dc.publisher | Springer Nature | en_US |
dc.relation.isversionof | 10.1038/s41467-022-28197-9 | en_US |
dc.relation.journal | Nature Communications | en_US |
dc.rights | Attribution 4.0 International | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | PMC | en_US |
dc.subject | Immunology | en_US |
dc.subject | Adjuvants | en_US |
dc.subject | Vaccines | en_US |
dc.subject | Adaptive immunity | en_US |
dc.title | A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice | en_US |
dc.type | Article | en_US |